A recent meta-analysis published in the Journal of the American College of Radiology evaluated the effectiveness of artificial intelligence (AI) in detecting various cancers through medical imaging. The analysis covered 49 randomized controlled trials (RCTs), with a significant focus on colorectal cancer (CRC), which constituted nearly 80% of the studies reviewed. Findings revealed a 22% increase in adenoma detection and a 20% increase in polyp detection for CRC, although AI had no significant effect on the detection of advanced adenomas or CRC itself. While AI-assisted detection showed improvements in other cancers—such as a 20% increase for breast cancer, a 40% enhancement for prostate cancer, and a marked improvement in lung cancer detection—the meta-analysis noted limitations due to the small number of RCTs for cancers beyond CRC and highlighted a lack of focus on patient-centered outcomes. The authors called for more comprehensive future research to assess AI's actual benefits and risks for patients.
Fri, 14 Nov 2025 12:04:07 GMT | diagnosticimaging.com